Preventing and Defending: 2 Keys to Reducing Clinical Validation...

shared a link

2023-02-15 11:46:14

https://www.healthleadersmedia.com/revenue-cycle/preventing-and-defending-2-keys-reducing-clinical-validation-denials-revenue-cycle?utm_source=HLeNL&utm_medium=email&utm_campaign=HLRevCycle
#enjoinCDI
#denialmanagement
#revenuecycle

https://www.healthleadersmedia.com/revenue-cycle/preventing-and-defending-2-keys-reducing-clinical-validation-denials-revenue-cycle?utm_source=HLeNL&utm_medium=email&utm_campaign=HLRevCycle #enjoinCDI #denialmanagement #revenuecycle

WWW.HEALTHLEADERSMEDIA.COM

Preventing and Defending: 2 Keys to Reducing Clinical Validation Denials in the Revenue Cycle

The director of CDI/utilization review at Avera Health reviews two key areas needed to shore up clinical validation denials.

1

0 Comments 0 Shares